Increasing equitable access to sexual and reproductive health (SRH) products is critical to saving lives and advancing gender equality.

SEMA Reproductive Health is a new, innovative partnership designed to build healthier, more equitable, and more resilient SRH markets so that women, girls, and people everywhere can control their bodies and futures.

Video preview

About Us

A NEW ERA FOR SEXUAL AND REPRODUCTIVE HEALTH MARKETS

SEMA Reproductive Health is a new partnership designed to ensure SRH markets provide sustained access to comprehensive, quality and affordable SRH products and services.

With countries and global organizations, SEMA will focus on aligning and strengthening market shaping efforts across geographies and private and public sectors through three core activity areas:

Market health

Proactively monitoring SRH market health by aggregating datasets and building a holistic, unified view of user demand and current market supply across regions and sectors.

Solutions

Identifying market barriers across geographies and co-designing strategic solutions tapping the unique strengths of existing networks and organizations in-country and globally.

Countries

Supporting countries and global partners to finance and implement interventions by helping governments mobilize domestic funding, crowding in new players, and coordinating global investments to maximize impact.

In all its activities, SEMA aims to shift the power of market stewardship to countries by supporting country-led strategies through locally-based operations.

Background

Global efforts in the last decade have enabled 60 million additional women and girls to access SRH products. However, for too many people around the world, contraceptives, medicines to manage pregnancy-related complications, and other SRH products remain unaffordable, unavailable, or simply don’t match individual preferences or lifestyles due to market inefficiencies or gaps.

These challenges spurred a multi-stakeholder Steering Committee to pursue a consultative process – engaging over 100 stakeholders globally – to imagine what healthier, more equitable, and more resilient SRH markets could look like.

Independent

Steering Committee Independent Representatives

  • Pape Amadou Gaye (Former President and CEO of IntraHealth International)
  • Prof. Isaac Adewole (Former Minister of Health, Nigeria)
  • Prof. Sheila Tlou (Former Minister of Health, Botswana)
  • Blair Hanewall (SEMA Coordination Lead)
Organizations

Steering Committee Organizations

  • Bill & Melinda Gates Foundation
  • Children’s Investment Fund Foundation (CIFF)
  • French Ministry for Europe and Foreign Affairs (MEAE)
  • UK Foreign, Commonwealth and Development Office (FCDO)
  • United Nations Population Fund (UNFPA)
  • United States Agency for International Development (USAID)

A GLOBAL PARTNERSHIP

SEMA was announced in July 2021 alongside the Generation Equality Forum in France, with country governments from Burkina Faso, Nigeria, and Uganda; financial support from the Children's Investment Fund Foundation (CIFF), Bill & Melinda Gates Foundation, and the French Ministry for Europe and Foreign Affairs (MEAE); and strategic partnership from the United States Agency for International Development (USAID), the Foreign, Commonwealth and Development Office of the United Kingdom (FCDO), United Nations Population Fund (UNFPA), and the Reproductive Health Supplies Coalition (RHSC).

The SEMA partnership will officially launch activities by the end of 2021, with operations based in Africa.

Burkina Faso Flag
NigeriaFlag
Nigeria Kaduna Flag
BMGF Logo
CIFF Logo
MEAE Logo

News & Resources

Careers

SEMA is hiring. See opportunities below.

Contact

For more information and to learn about becoming a SEMA partner, you can write to us using the form below.